SPONSOR
Chongqing Precision Biotech Co., Ltd
Total Trials
2
Recruiting
2
Phases
Phase 1
Conditions studied: Gastric CancerColon CancerRectal CancerBreast CancerLung CancerEsophagus CancerCholangiocarcinomaPancreas CancerSLE (Systemic Lupus)Sjogren's Syndrome
Chongqing Precision Biotech Co., Ltd is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Gastric Cancer, Colon Cancer, Rectal Cancer, Breast Cancer.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Chongqing Precision Biotech Co., Ltd
How many clinical trials has Chongqing Precision Biotech Co., Ltd sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Chongqing Precision Biotech Co., Ltd, of which 2 are actively recruiting participants. These trials cover conditions including Gastric Cancer, Colon Cancer, Rectal Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Chongqing Precision Biotech Co., Ltd research focus on?
Chongqing Precision Biotech Co., Ltd clinical trials span Gastric Cancer, Colon Cancer, Rectal Cancer, Breast Cancer, Lung Cancer, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Chongqing Precision Biotech Co., Ltd clinical trial?
To participate in a Chongqing Precision Biotech Co., Ltd trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Chongqing Precision Biotech Co., Ltd trials with current recruitment status updated daily.
Clinical Trials by Chongqing Precision Biotech Co., Ltd
NCT06126406 Phase 1
Recruiting
Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors
Gastric Cancer
NCT06056921 Phase 1
Recruiting
Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
SLE (Systemic Lupus)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology